Optain Health discloses $7.47 million equity financing
The retinal imaging company reported 22 investors, with $5.53 million of its offering still unsold.
Optain Health reported $7,468,988 sold to 22 investors in a Form D filed on October 13, 2026. The notice lists equity securities and a first sale on September 16.
The $12,999,965 target left $5,530,977 unsold at filing. The investors are not identified, and the notice does not provide a named venture round stage.
Optain combines retinal imaging with AI software to help clinicians screen for eye diseases. Its Eyetelligence Assure software and camera produce risk assessment reports that support decisions about further examination and care.